Lantern Pharma, Inc. (LTRN)
2.73
-0.09
(-3.19%)
USD |
NASDAQ |
Mar 05, 16:00
2.70
-0.03
(-1.10%)
After-Hours: 20:00
Lantern Pharma Cash from Investing (Quarterly) : 5.928M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
| Savara, Inc. | 21.47M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
| Imunon, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.572M |
| Cash from Financing (Quarterly) | 0.9718M |
| Free Cash Flow | -16.86M |
| Free Cash Flow Per Share (Quarterly) | -0.4221 |
| Free Cash Flow to Equity (Quarterly) | -4.522M |
| Free Cash Flow to Firm (Quarterly) | -4.573M |
| Free Cash Flow Yield | -57.21% |